Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
PaperCitations, authors & open-access status
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 340 citations, 2012 year and bronze oa status.
340
Citations
2012
Year
bronze
OA Status